Barclays’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$176K Buy
24,004
+15,553
+184% +$114K ﹤0.01% 3609
2025
Q1
$65K Sell
8,451
-2,092
-20% -$16.1K ﹤0.01% 3819
2024
Q4
$128K Buy
10,543
+1,255
+14% +$15.2K ﹤0.01% 3724
2024
Q3
$116K Buy
9,288
+6,855
+282% +$85.6K ﹤0.01% 3704
2024
Q2
$29K Buy
+2,433
New +$29K ﹤0.01% 3830
2023
Q4
Sell
-4,014
Closed -$29K 4256
2023
Q3
$29K Hold
4,014
﹤0.01% 3796
2023
Q2
$21K Hold
4,014
﹤0.01% 3965
2023
Q1
$12K Hold
4,014
﹤0.01% 4057
2022
Q4
$16K Hold
4,014
﹤0.01% 4065
2022
Q3
$15K Hold
4,014
﹤0.01% 4039
2022
Q2
$54K Hold
4,014
﹤0.01% 3702
2022
Q1
$20K Hold
4,014
﹤0.01% 4326
2021
Q4
$28K Sell
4,014
-499
-11% -$3.48K ﹤0.01% 3083
2021
Q3
$139K Buy
4,513
+29
+0.6% +$893 ﹤0.01% 3111
2021
Q2
$145K Sell
4,484
-2,961
-40% -$95.8K ﹤0.01% 3009
2021
Q1
$282K Buy
7,445
+3,569
+92% +$135K ﹤0.01% 2976
2020
Q4
$183K Sell
3,876
-392
-9% -$18.5K ﹤0.01% 2733
2020
Q3
$137K Buy
4,268
+2,055
+93% +$66K ﹤0.01% 2901
2020
Q2
$97K Buy
2,213
+2,209
+55,225% +$96.8K ﹤0.01% 3133
2020
Q1
$0 Sell
4
-108
-96% ﹤0.01% 3756
2019
Q4
$6K Sell
112
-146
-57% -$7.82K ﹤0.01% 3750
2019
Q3
$9K Sell
258
-4,427
-94% -$154K ﹤0.01% 3911
2019
Q2
$259K Buy
4,685
+4,196
+858% +$232K ﹤0.01% 3067
2019
Q1
$29K Buy
489
+439
+878% +$26K ﹤0.01% 3832
2018
Q4
$3K Sell
50
-2,453
-98% -$147K ﹤0.01% 3846
2018
Q3
$202K Sell
2,503
-2,683
-52% -$217K ﹤0.01% 3063
2018
Q2
$454K Buy
5,186
+4,795
+1,226% +$420K ﹤0.01% 2338
2018
Q1
$76K Buy
391
+347
+789% +$67.4K ﹤0.01% 3302
2017
Q4
$5K Buy
44
+40
+1,000% +$4.55K ﹤0.01% 3894
2017
Q3
$0 Hold
4
﹤0.01% 4059
2017
Q2
$0 Buy
+4
New ﹤0.01% 3947
2014
Q4
Sell
-1
Closed -$2K 4201
2014
Q3
$2K Sell
1
-81
-99% -$162K ﹤0.01% 4126
2014
Q2
$258K Sell
82
-22
-21% -$69.2K ﹤0.01% 2276
2014
Q1
$328K Buy
104
+86
+478% +$271K ﹤0.01% 2149
2013
Q4
$55K Buy
18
+11
+157% +$33.6K ﹤0.01% 3332
2013
Q3
$28K Sell
7
-95
-93% -$380K ﹤0.01% 3393
2013
Q2
$345K Buy
+102
New +$345K ﹤0.01% 2424